Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Qiagen
QGEN
$8.87B
| $9.11M | ﹤0.01% |
162,544
-390,075
| -71% | -$20.8M |
|
2652
CALL
PTC
PTC
$16.2B
| $9.1M | ﹤0.01% |
76,100
+17,800
| +31% | +$1.77M |
|
2653
Aldeyra Therapeutics
ALDX
$94.1M
| $9.09M | ﹤0.01% |
1,325,687
+296,868
| +29% | +$2.08M |
|
2654
PUT
Molina Healthcare
MOH
$11.1B
| $9.08M | ﹤0.01% |
42,700
-5,900
| -12% | -$1.22M |
|
2655
CALL
Vipshop
VIPS
$6.81B
| $9.06M | ﹤0.01% |
322,400
+144,900
| +82% | +$3.21M |
|
2656
CALL
HEICO Corp
HEI
$52.4B
| $9.04M | ﹤0.01% |
68,300
+42,900
| +169% | +$5.23M |
|
2657
Upbound Group
UPBD
$1.14B
| $9.04M | ﹤0.01% |
236,036
+88,558
| +60% | +$3.01M |
|
2658
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $9.03M | ﹤0.01% |
+322,468
| New | +$9.02M |
|
2659
ICICI Bank
IBN
$107B
| $9.03M | ﹤0.01% |
607,591
+297,894
| +96% | +$3.74M |
|
|
LNFA.U
2660
DELISTED
L&F Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one rede
LNFA.U
| $9.02M | ﹤0.01% |
+870,009
| New | +$8.87M |
|
2661
iShares Select Dividend ETF
DVY
$24.1B
| $9.02M | ﹤0.01% |
93,753
-48,210
| -34% | -$4.38M |
|
2662
Ares Management
ARES
$32.5B
| $9M | ﹤0.01% |
191,257
-486,166
| -72% | -$22M |
|
2663
PUT
Fastenal
FAST
$58.5B
| $8.99M | ﹤0.01% |
368,400
-50,400
| -12% | -$1.19M |
|
|
BBBY
2664
Bed Bath & Beyond
BBBY
$415M
| $8.99M | ﹤0.01% |
206,108
+84,799
| +70% | +$5.02M |
|
2665
Groupon
GRPN
$875M
| $8.99M | ﹤0.01% |
236,509
+96,038
| +68% | +$2.64M |
|
2666
iShares Core S&P Small-Cap ETF
IJR
$114B
| $8.98M | ﹤0.01% |
+97,768
| New | +$8.03M |
|
|
LHCG
2667
DELISTED
LHC Group LLC
LHCG
| $8.98M | ﹤0.01% |
42,096
+41,057
| +3,952% | +$8.74M |
|
2668
JPMorgan US Quality Factor ETF
JQUA
$8.63B
| $8.96M | ﹤0.01% |
249,802
+228,132
| +1,053% | +$7.81M |
|
2669
PUT
Nutanix
NTNX
$18B
| $8.96M | ﹤0.01% |
281,200
-116,500
| -29% | -$3.16M |
|
2670
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $8.96M | ﹤0.01% |
+280,872
| New | +$8.41M |
|
2671
CALL
Williams Companies
WMB
$92B
| $8.96M | ﹤0.01% |
446,900
-291,700
| -39% | -$5.91M |
|
2672
Pulmonx
LUNG
$104M
| $8.96M | ﹤0.01% |
+129,745
| New | +$6.35M |
|
2673
PUT
GrowGeneration
GRWG
$104M
| $8.95M | ﹤0.01% |
222,600
+16,500
| +8% | +$444K |
|
|
RVNC
2674
PUT
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.94M | ﹤0.01% |
315,600
-300
| -0.1% | -$7.77K |
|
2675
CALL
Carlyle Group
CG
$17.6B
| $8.94M | ﹤0.01% |
284,200
-97,800
| -26% | -$2.75M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.